Neurons are highly dependent on mitochondrial function, and mitochondrial damage has been implicated in many neurological and neurodegenerative diseases. Relatively little is known about how mitochondria regulate neuronal function. Here we show that axonal mitochondria are necessary for neuropeptide secretion in Caenorhabditis elegans, and that oxidative phosphorylation, but not mitochondrial calcium uptake, is required for secretion. Oxidative phosphorylation produces cellular ATP, reactive oxygen species, and consumes oxygen.
INTRODUCTION
Mutations that perturb mitochondrial function are linked to several neurodevelopmental and neurodegenerative disorders (JOHRI AND BEAL 2012; PEASE AND SEGAL 2014; PICKRELL AND YOULE 2015; KERR et al. 2017; KRENCH AND LITTLETON 2017) .
For these reasons, there is significant interest in defining the cell biological mechanisms through which mitochondria regulate neuronal function and development. Mutations (or drug treatments) that impair mitochondrial function cause widespread cellular and developmental defects. Given these pleiotropic effects, identifying the precise molecular pathways through which mitochondria regulate neural development and behavior has proved challenging. One strategy to circumvent this problem has been to analyze mutants in which mitochondria transport or localization in axons is blocked (GUO et al. 2005; VERSTREKEN et al. 2005; KANG et al. 2008; MA et al. 2009; RUSSO et al. 2009 ). In these transport mutants, mitochondrial defects are restricted to axons, whereas other cellular functions of mitochondria remain intact.
Analysis of mitochondria transport mutants suggests mitochondria can act through multiple pathways to influence neuronal function and development. Several aspects of neuronal function are especially dependent upon cellular energy stores (e.g. maintenance of membrane potential, intracellular transport to axons and dendrites, and membrane fusion and endocytosis reactions). In addition to producing ATP, mitochondria also act as an intracellular calcium store; consequently, axonal mitochondria alter the duration of presynaptic calcium transients thereby regulating neurotransmitter release at synapses (WERTH AND THAYER 1994;  TANG AND ZUCKER 1997; BILLUPS AND FORSYTHE 2002; MEDLER AND GLEASON 2002) .
Finally, mitochondria promote axon regeneration following injury (RAWSON et al. 2014; HAN et al. 2016) . Given the widespread effects of mitochondria on cellular physiology, it is likely 5 that additional mechanisms will be discovered that link mitochondria to neuronal function and development.
To further investigate how they impact neuronal function, we asked if axonal mitochondria regulate secretion of neuropeptides. Neuropeptides are a chemically diverse set of neuromodulators that are recognized by G protein coupled receptors (GPCRs). GPCRs typically bind their cognate ligands with extremely high affinity and stimulate production of second messengers through G-protein activation of enzymatic targets. Consequently, neuropeptides (and other metabotropic agonists) often produce relatively long-lasting signals over very large spatial domains. Thus, we hypothesized that axonal mitochondria could alter global behavioral states by regulating neuropeptide secretion. Here we show that axonal mitochondria promote neuropeptide secretion and that they do so by regulating a cellautonomous stress response to hypoxia.
(mtruck) construct was adapted from the original version (RAWSON et al. 2014) to contain the following elements (listed 5' to 3'): the snb-1 promoter (for locomotion and aldicarb assays) or the unc-129 promoter (for imaging), the cDNA for unc-116, linker sequence, GFP (for locomotion and aldicarb) or TagRFP (for imaging) with syntrons, att recombination site + second linker, the genomic sequence of tomm-7, and the let-858 3'UTR.
The TOMM-20-mCherry construct contains the unc-129 promoter, the sequence encoding the first 53 amino acids of TOM-20 carrying the mitochondrial localization signal, att recombination site, mCherry with syntrons, and the unc-54 3'UTR. The Punc-129::SNP-1-GFP construct was previously described (SIEBURTH et al. 2005) .
For the Punc-129::NLP-21-mNeonGreen construct the unc-129 promoter, the nlp-21-minigene (coding region plus two syntrons), mNeonGreen with syntrons, and the let-858 3'UTR were inserted into the miniMOS vector pCFJ910. Single copy insertion (nuSi187) of this transgene was obtained as described (FROKJAER-JENSEN et al. 2014) . The Punc-129::NLP-21-YFP (nuIs183) transgenic line was previously described (SIEBURTH et al. 2007 ).
The cell-specific rescue constructs contain the unc-129 promoter, the open reading frame including introns (nuo-6, vhl-1) or the cDNA (sod-2) of the rescuing gene, and the unc-54 3'UTR. The vhl-1 genomic rescue construct contains the genomic vhl-1 locus spanning the region 1.5 kb upstream of the start codon to 0.8 kb downstream of the stop codon.
Drug, hypoxia, and RNAi assays
Acute aldicarb assays were performed blind in five replicates on young adult worms as described (NURRISH et al. 1999) . Locomotion was measured by transferring adults to unseeded plates and recording their movement at 2 Hz for 30 s on a Zeiss Discovery Steromicroscope 9 using Axiovision software. The centroid velocity of each animal was analyzed at each frame using object-tracking software in Axiovision. The speed of each animal was calculated by averaging the velocity value at each frame.
For treatment of worms with varying oxygen levels, worms were picked onto a fresh plate at the L4 stage and the plate was put into a Hypoxia Incubator Chamber (STEMCELL Technologies). Using a MINIOS 1 oxygen analyser (MEDIQUIP), the chamber was then filled with oxygen (for hyperoxia) or nitrogen until the oxygen test concentration was reached.
Worms were left to grow at control and test oxygen levels for 24 hours and coelomocytes were imaged subsequently.
RNAi was performed in the neuronal RNAi hypersensitive mutant background (nre-1 lin-15b) (SCHMITZ et al. 2007) . One-day old hermaphrodites were dropped into bleach on RNAi plates. When the progeny reached L4 stage, worms were transferred onto a fresh RNAi plate and scored for coelomocyte fluorescence 24 hours later.
Fluorescence microscopy and quantitative analysis
Worms were immobilized on 10% agarose pads with 0.1 um diameter polystyrene 501 microspheres (Polysciences 00876-15, 2.5% w/v suspension). For axonal fluorescence measurements, the dorsal nerve cord (midway between the vulva and the tail) was captured using a 60x objective (NA 1.45) on an Olympus FV-1000 confocal microscope at 5× digital zoom. Maximum intensity projections of z-series stacks were made using Metamorph 7.1 software (Molecular Devices, Sunnyvale, CA, United States). Line scans of dorsal cord fluorescence were analyzed in Igor Pro (WaveMetrics, Lake Oswego, OR, United States) using custom-written software (BURBEA et al. 2002; DITTMAN AND KAPLAN 2006) . 
RESULTS

Axonal mitochondria promote neuropeptide secretion
In a prior study, we showed that mutations inactivating the C. elegans ric-7 gene significantly reduced neuropeptide secretion (which is mediated by exocytosis of dense core vesicles, DCVs) but had little effect on acetylcholine release (which is mediated by exocytosis of synaptic vesicles, SVs) (HAO et al. 2012) . These results imply that RIC-7 plays a specific role in promoting exocytosis of DCVs but not SVs. Decreased neuropeptide secretion in ric-7 mutants was accompanied by decreased locomotion rate, and increased resistance to the paralytic effects of aldicarb (an acetylcholinesterase inhibitor) (HAO et al. 2012) . Homologs of ric-7 are found in other nematodes but not in other metazoans. The ric-7 gene encodes an unfamiliar protein that lacks any previously described structural domain. Thus, the sequence of the RIC-7 protein failed to provide any clues as to the cell biological mechanism underlying RIC-7's function in neuropeptide secretion.
A subsequent study showed that RIC-7 is required for kinesin-1 mediated transport of mitochondria into axons (RAWSON et al. 2014) . These results suggest that the behavioral and neuropeptide secretion defects observed in ric-7 mutants could be caused by the absence of axonal mitochondria. To test this idea, we expressed a chimeric kinesin construct (mtruck) in which UNC-116/KIF5 is fused to the outer mitochondrial membrane protein TOM-7. As previously reported (RAWSON et al. 2014) , the mtruck transgene rescued the ric-7 mitochondrial transport defect (Fig. 1A, B) . Neuronal expression of mtruck significantly improved locomotion and decreased the aldicarb resistance of ric-7 mutants (Fig. 1C, D) , suggesting that ric-7 behavioral defects are caused by the lack of axonal mitochondria.
To assay neuropeptide secretion, we expressed the proneuropeptide NLP-21 tagged with YFP in the cholinergic DA/DB motor neurons (using the unc-129 promoter). We fluorescence defects exhibited by ric-7 mutants were rescued by expressing mtruck in the DA/DB neurons ( Fig. 1E-G) . Thus, the ric-7 behavioral and neuropeptide secretion defects are both caused by the absence of axonal mitochondria.
Neuropeptide secretion requires oxidative phosphorylation but not mitochondrial calcium uptake
Loss of axonal mitochondria is predicted to result in multiple defects. For example, mitochondria regulate cytoplasmic calcium levels by taking up calcium through the Mitochondrial Calcium Uniporter (MCU) (KIRICHOK et al. 2004; BAUGHMAN et al. 2011; DE STEFANI et al. 2011) , which could account for the ric-7 neuropeptide secretion defect. To test this idea, we analyzed two independent mcu-1 null mutants, finding no significant changes in NLP-21 coelomocyte and axonal puncta fluorescence ( Fig. 2A, B) . These results suggest that 13 changes in mitochondrial calcium uptake are unlikely to account for the ric-7 mutant neuropeptide secretion defects.
Next, we asked if neuropeptide secretion requires mitochondrial respiration. Mutations in the nuo-6, isp-1, and mev-1 genes (which encode components of complex I, II, and III, respectively) reduce respiration rate YANG AND HEKIMI 2010b; PFEIFFER et al. 2011; YEE et al. 2014) . These oxidative phosphorylation mutants also had decreased NLP-21 coelomocyte fluorescence, indicating decreased neuropeptide secretion (Fig. 2C, D) . The nuo-6 NLP-21 secretion defect was rescued by a transgene restoring NUO-6 expression specifically in the DA/DB neurons ( Fig. 2D , E). These results support the idea that mitochondrial respiration acts in a cell-autonomous manner to promote neuropeptide secretion from DA/DB neurons.
Increased mitochondrial ROS inhibits neuropeptide secretion
Disrupting oxidative phosphorylation can lead to reduced ATP levels and altered production of reactive oxygen species (ROS) (SENOO-MATSUDA et al. 2001; YANG AND HEKIMI 2010a; YEE et al. 2014) , both of which could affect neuropeptide secretion. Several steps in neurotransmission, such as establishment and maintenance of membrane potential and membrane fusion, are known to require ATP. Accordingly, we found that mutants of glycolytic enzymes also have decreased neuropeptide secretion (Fig. S1A ).
Conflicting results have been reported for the effects of mev-1, isp-1, and nuo-6 mutations on ATP levels (SENOO-MATSUDA et al. 2001; YANG AND HEKIMI 2010a; YANG AND HEKIMI 2010b; YEE et al. 2014) . In addition, several findings suggest that neurotransmission may be more reliant on glycolysis than oxidative phosphorylation to meet its energy demands (RANGARAJU et al. 2014; JANG et al. 2016; .
Prompted by these results, we investigated other potential mechanisms for neuropeptide secretion defects in the oxidative phosphorylation deficient mutants. Since mev-1, isp-1, and nuo-6 mutants have all been shown to increase ROS levels SENOO-MATSUDA et al. 2001; LEE et al. 2010; YANG AND HEKIMI 2010a; YANG AND HEKIMI 2010b; YEE et al. 2014) , we hypothesized that altered ROS production might contribute to decreased secretion in these mutants. To test this idea, we measured NLP-21 coelomocyte fluorescence in mutants lacking ROS detoxification enzymes. Superoxide dismutases (SODs) convert superoxide to hydrogen peroxide (H 2 O 2 ), which can then be broken down to water by catalase (Fig. 3A) . In C. elegans, the genes sod-1 and sod-5 encode the cytoplasmic Cu/ZnSODs (LARSEN 1993; JENSEN AND CULOTTA 2005); sod-2 and sod-3 encode the mitochondrial MnSODs (GIGLIO et al. 1994; SUZUKI et al. 1996; HUNTER et al. 1997) ; and sod-4 encodes an extracellular Cu/ZnSOD . We analyzed NLP-21 secretion in all five SOD mutants (Fig. S1B, C) . In sod-2 mutants (which lack the main mitochondrial SOD), NLP-21 secretion was significantly reduced, as indicated by decreased NLP-21 coelomocyte fluorescence and increased NLP-21 axonal punctal fluorescence, both of which were rescued by a transgene restoring sod-2 expression in DA/DB neurons (Fig. 3B, C) . Thus, ric-7 and sod-2 mutants exhibited very similar defects in NLP-21 secretion, suggesting that SOD-2 and RIC-7 function together to promote NLP-21 secretion. Consistent with this idea, we found that the NLP-21 coelomocyte fluorescence defect observed in sod-2; ric-7 double mutants was not significantly different from that observed in ric-7 single mutant (Fig. 3D) . Collectively, these results suggest that perturbing mitochondrial ROS detoxification in axons inhibits NLP-21 secretion.
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To determine if increased cytoplasmic ROS levels regulate NLP-21 secretion, we analyzed sod-1 mutants, which lack the major cytoplasmic SOD. In sod-1 mutants, we expect increased cytoplasmic superoxide and decreased cytoplasmic H 2 O 2 . Unlike sod-2 mutants, NLP-21 secretion was significantly increased in sod-1 mutants (Fig. S1B) . These results suggest that mitochondrial and cytoplasmic ROS have opposite effects on neuropeptide secretion. Taken together, these results support the idea that neuropeptide secretion is strongly inhibited by a variety of mitochondrial defects, including mutations disrupting axonal transport of mitochondria, mutations disrupting mitochondrial respiration, and mutations increasing mitochondrial ROS levels. Furthermore, in each case mitochondria act cellautonomously to promote neuropeptide secretion.
Hypoxia inhibits neuropeptide secretion
The neuropeptide secretion defects observed in mitochondrial mutants could result from decreased levels of ATP or other metabolites. Alternatively, decreased neuropeptide secretion could result from activation of stress response pathways. Several stress response pathways are induced in mitochondrial mutants, including those mediated by the hypoxia inducible factor (HIF-1), SKN-1/Nrf2, the mitochondrial unfolded protein response, and the AMP activated protein kinase (SENA AND CHANDEL 2012; HWANG et al. 2014; BLACKWELL et al. 2015; CHANG et al. 2017; DUES et al. 2017 ; SHPILKA AND HAYNES 2018).
We focused on HIF-1 because ric-7 mutants display hypoxic phenotypes (JANG et al. 2016 ) and mutations decreasing mitochondrial respiration stabilize HIF-1 (LEE et al. 2010; HWANG et al. 2014) . Prompted by these results, we hypothesized that ric-7 mutants might undergo a hypoxic response that inhibits neuropeptide release. We did several experiments to test this idea. First, we asked if growth in reduced oxygen tension inhibits neuropeptide secretion. Consistent with this idea, growing wildtype animals in a hypoxic chamber (5 or 10% oxygen) for 24 hours significantly reduced NLP-21 coelomocyte fluorescence (Fig. 4A) .
By contrast, growth in hyperoxic conditions (100% oxygen) for the same duration had no effect (Fig. S2A) . Thus, hypoxia was sufficient to inhibit NLP-21 secretion.
Next, we asked if activation of HIF-1 was sufficient to inhibit NLP-21 secretion. To test this idea, we analyzed vhl-1 mutants. VHL-1 is the C. elegans ortholog of the von Hippel Lindau tumor suppressor protein, which promotes HIF-1 ubiquitination under normoxic conditions. In vhl-1 mutants, HIF-1 is stabilized and constitutively activates the hypoxic transcriptional response (KAELIN 2007) . As expected, NLP-21 coelomocyte fluorescence was significantly decreased in vhl-1 mutants and this defect was rescued by a transgene that restores VHL-1 expression specifically in the DA/DB neurons (Fig. 4B) . The NLP-21 secretion defect in vhl-1 mutants was abolished in hif-1; vhl-1 double mutants, confirming that the vhl-1 secretion defect was a consequence of stabilized HIF-1 (Fig. 4C) . Taken together, these results suggest that activation of the HIF-1 hypoxia response in DA/DB neurons is sufficient to inhibit NLP-21 secretion.
Does activation of HIF-1 account for the ric-7 neuropeptide secretion defect? We did two experiments to test this idea. First, if ric-7 mutations inhibit neuropeptide secretion by activating the hypoxic response, then hif-1 mutations should restore secretion in these mutants.
As predicted, ric-7 hif-1 double mutants had significantly higher NLP-21 coelomocyte fluorescence than ric-7 single mutants (Fig. 4D ). This effect was specific because inactivating two other stress-activated transcription factors (DAF-16/FOXO and SKN-1/Nrf) did not increase NLP-21 coelomocyte fluorescence in ric-7 mutants (Fig. S2B, C) (Fig. 4C) . By contrast, vhl-1 and unc-31/CAPS mutations did have additive effects on NLP-21 secretion in double mutants (Fig. S2D) .
Collectively, these results support the idea that lack of axonal mitochondria (in ric-7 mutants) elicits a cell-autonomous hypoxic response that stabilizes HIF-1 and inhibits neuropeptide secretion.
DISCUSSION
Here, we show that axonal transport of mitochondria is critical for neuropeptide release and locomotion in C. elegans. Impaired mitochondrial transport, reduced oxidative phosphorylation rates, and increased mitochondrial ROS levels all inhibited neuropeptide secretion cell-autonomously, whereas interfering with mitochondrial calcium uptake had no effect. The effects of axonal mitochondria on neuropeptide release are mediated (at least in part) by changes in HIF-1 activity. Activating HIF-1 inhibited neuropeptide secretion while hif-1 null mutations partially restored secretion in mutants lacking axonal mitochondria. These results demonstrate that modifications of mitochondrial transport or function lead to cellautonomous changes in neuropeptide secretion, thus providing a mechanism whereby the metabolic or redox state of a neuron could alter the global behavioral state of the animal.
Mitochondrial transport mutants as a model to identify mitochondrial function in neurotransmission
Blocking mitochondrial transport into axons can result in a variety of synaptic defects by a number of different mechanisms. For example, mouse syntabulin knockouts are defective for mitochondrial transport in cultured superior cervical ganglion neurons, which is accompanied by accelerated synaptic depression, slowed recovery after synaptic vesicle depletion, and impaired short-term plasticity (MA et al. 2009 ). In contrast, decreased axonal mitochondria in rat syntaphilin mutant hippocampal neurons slow presynaptic calcium clearance and enhance short-term facilitation (KANG et al. 2008) . Here, we find that the absence of axonal mitochondria induces a hypoxic response that inhibits neuropeptide secretion, thus identifying a new mechanism by which mitochondrial transport defects alter neurotransmission. Although ric-7 is not conserved beyond nematodes and has no recognizable structural domains, it is conceivable that RIC-7 functions analogously to syntabulin (which is a KIF5B cargo adaptor for mitochondrial transport) (MA et al. 2009 ).
While it is likely that RIC-7 promotes transport of other unidentified cargoes, restoring axonal mitochondria in ric-7 mutants (by expressing mtruck) rescued the NLP-21 secretion defects.
Thus, mitochondrial transport defects alone account for the impaired neuropeptide secretion of ric-7 mutants.
Neuropeptide secretion does not require the mitochondrial calcium uniporter MCU-1
Mitochondrial calcium uptake regulates synaptic strength in a variety of systems (RIZZUTO et al. 1998; EMPTAGE et al. 2001; LIANG et al. 2002; BOUCHARD et al. 2003; DE JUAN-SANZ et al. 2017) .
Three matrix dehydrogenases are activated by calcium ions, thus coupling mitochondrial calcium levels to bioenergetics and metabolic flux (DENTON AND MCCORMACK 1980 (FENG et al. 2013; MURPHY et al. 2014 ). The residual mitochondrial calcium levels may be sufficient to allow mcu-1 mutant worms to sustain normal levels of neuropeptide secretion.
Increased mitochondrial ROS inhibits neuropeptide secretion
Two findings in this study suggest that increased mitochondrial ROS inhibits neuropeptide secretion cell-autonomously. First, neuropeptide secretion is reduced in mutants lacking the major mitochondrial superoxide dismutase, sod-2. Second, mutations in the genes nuo-6, mev-1, and isp-1 all lead to elevated mitochondrial ROS levels (SENOO-MATSUDA et al. neurons elicits a stress response in the intestine (BERENDZEN et al. 2016; SHAO et al. 2016) . In this case, the non-autonomous effect of ROS was mediated by increased neuronal secretion of serotonin and FLP-2. By contrast, we observed decreased NLP-21 secretion in motor neurons when mitochondrial function was impaired. Taken together, these results suggest that mitochondria can either promote (FLP-2) or inhibit (NLP-21) neuropeptide secretion, depending on the activating stimulus and cell type. by mutation of sod-1 shortens lifespan whereas increase of mitochondrial ROS by sod-2 mutation increases lifespan (SCHAAR et al. 2015) . How different subcellular localizations of ROS produce distinct phenotypes is poorly understood. One possible scenario could be that accumulation of cytoplasmic ROS in sod-1 mutants has a more direct and higher impact on other compartments, such as the endoplasmatic reticulum (ER), than the increase of mitochondrial ROS in sod-2 mutants. Disrupting the ER's redox state is likely to interfere with protein folding and, consequently, could activate the ER unfolded protein response (UPR ER ), thereby altering expression of a broad group of genes. It will be interesting to determine if activating the UPR ER also alters neuropeptide secretion in a cell-autonomous manner.
Activation of the hypoxic response by multiple pathways
Acute neural activity relies on an increase in oxidative phosphorylation for ATP supply, which results in decreased oxygen levels (HALL et al. 2012; RANGARAJU et al. 2014) .
Therefore, oxygen depletion and HIF-1 activation provide a way to sense and adapt to metabolic stress. At normal oxygen levels, HIF-1 is continually hydroxylated by oxygendependent prolyl hydroxlyases. Hydroxylated HIF-1 is ubiquitinated by an E3 ligase containing VHL-1, which results in HIF-1 degradation. During hypoxia, the prolyl hydroxylases are inactive and HIF-1 becomes stabilized, initiating transcription of a variety of genes to adapt to the hypoxic condition. Prior studies suggest that mutations altering mitochondrial respiration can also stabilize HIF-1 (LEE et al. 2010; HWANG et al. 2014) .
Mitochondria have been proposed to regulate HIF-1 stability through a variety of mechanisms.
Mitochondrially produced ROS are proposed to directly activate HIF-1 (CHANDEL et al. 2000; BRUNELLE et al. 2005; GUZY et al. 2005; MANSFIELD et al. 2005) . Other studies suggest that altered abundance of mitochondrial metabolites stabilize HIF-1 (LU et al. 2005; HEWITSON et al. 2007; KOIVUNEN et al. 2007; MISHUR et al. 2016) . Therefore, HIF-1 could become activated in ric-7 mutants because the absence of mitochondria results in elevated ROS production or altered abundance of mitochondrial metabolites. NLP-21 secretion was inhibited when HIF-1 was activated by vhl-1 mutations, by hypoxic growth conditions, or by mutations altering mitochondrial respiration and ROS levels. Thus, our results are compatible with either mechanism.
Activating HIF-1 initiates a comprehensive transcriptional program that, among others, reduces oxidative phosphorylation and promotes glycolysis (WANG et al. 1995; RANKIN AND 23 GIACCIA 2016) . Activated HIF-1 also promotes axon regeneration following injury (NIX et al. 2014; CHO et al. 2015; ALAM et al. 2016) , suggesting a neuroprotective role in certain conditions. This study identifies a new role for HIF-1 in inhibiting neuropeptide secretion,
indicating that in addition to cell-autonomous metabolic rewiring, activation of HIF-1 might (directly or indirectly) alter intercellular signaling, thus facilitating the communication of cellspecific stresses to different cells and tissues to induce broad physiological changes. Values that differ significantly are indicated (****, p < 0.0001, ANOVA). 
